{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:58:37Z","timestamp":1726761517527},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00104-019-0989-y","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T12:04:45Z","timestamp":1560945885000},"page":"681-694","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hypertherme intrathorakale Chemotherapie in der Thoraxchirurgie"],"prefix":"10.1007","volume":"90","author":[{"given":"H.-S.","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"989_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1200\/JCO.1992.10.6.1001","volume":"10","author":"VW Rusch","year":"1992","unstructured":"Rusch VW, Niedzwiecki D, Tao Y et\u00a0al (1992) Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. J\u00a0Clin Oncol 10:1001\u20131006","journal-title":"J Clin Oncol"},{"issue":"6","key":"989_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00104-010-1926-2","volume":"81","author":"HS Hofmann","year":"2010","unstructured":"Hofmann HS, Wiebe K (2010) Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion. Chirurg 81(6):557\u2013562","journal-title":"Chirurg"},{"key":"989_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1378\/chest.121.2.480","volume":"121","author":"E De Bree","year":"2002","unstructured":"De Bree E, van Ruth S, Baas P et\u00a0al (2002) Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 121:480\u2013487","journal-title":"Chest"},{"issue":"4","key":"989_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ejcts\/ezs418","volume":"43","author":"M Ried","year":"2012","unstructured":"Ried M, Potzger T, Braune N et\u00a0al (2012) Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumors: perioperative management and clinical experience. Eur J Cardiothorac Surg 43(4):801\u2013807","journal-title":"Eur J Cardiothorac Surg"},{"key":"989_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0003-4975(94)00614-D","volume":"59","author":"Y Matsuzaki","year":"1995","unstructured":"Matsuzaki Y, Shibata K, Yoshioka M et al (1995) Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion. Ann Thorac Surg 59:127\u2013131","journal-title":"Ann Thorac Surg"},{"key":"989_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/fon.14.256","volume":"11","author":"M Migliore","year":"2015","unstructured":"Migliore M, Calvo D, Criscione A et\u00a0al (2015) Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience. Future Oncol 11:47\u201352","journal-title":"Future Oncol"},{"key":"989_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1245\/ASO.2003.03.022","volume":"10","author":"S Van Ruth","year":"2003","unstructured":"Van Ruth S, Baas P, Haas R, Rutgers E, Verwaal V, Zoetmulder FA (2003) Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma. Ann Surg Oncol 10:176\u2013182","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"989_CR8","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"D Rice","year":"2011","unstructured":"Rice D, Rusch V, Pass H et\u00a0al (2011) Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a\u00a0consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J\u00a0Thorac Oncol 6(8):1304\u20131312","journal-title":"J Thorac Oncol"},{"key":"989_CR9","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","volume":"24","author":"WG Richards","year":"2006","unstructured":"Richards WG, Zellos L, Bueno R et\u00a0al (2006) Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J\u00a0Clin Oncol 24:1561\u20131567","journal-title":"J Clin Oncol"},{"issue":"2","key":"989_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","volume":"138","author":"TR Tillemann","year":"2009","unstructured":"Tillemann TR, Richards WG, Zellos L et\u00a0al (2009) Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study. J\u00a0Thorac Cardiovasc Surg 138(2):405\u2013411","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"989_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","volume":"145","author":"DJ Sugarbaker","year":"2013","unstructured":"Sugarbaker DJ, Gill RR, Yeap BY et al (2013) Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J\u00a0Thorac Cardiovasc Surg 145(4):955\u2013963","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"989_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jtcvs.2008.07.055","volume":"137","author":"L Zellos","year":"2009","unstructured":"Zellos L, Richards WG, Capalbo L et\u00a0al (2009) A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant mesothelioma. J\u00a0Thorac Cardiovasc Surg 137(2):453\u2013458","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"989_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtcvs.2012.10.013","volume":"145","author":"A Yellin","year":"2013","unstructured":"Yellin A, Simansky DA, Ben-Avi R et al (2013) Resection and heated pleural chemoperfusion in patients with thymic\u00a0epithelial malignant disease and pleural spread: a\u00a0single-institution experience. J\u00a0Thorac Cardiovasc Surg 145(1):83\u201389","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"989_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/a-0573-2419","volume":"143","author":"M Ried","year":"2018","unstructured":"Ried M, Hofmann HS, Dienemann H, Eichhorn M (2018) Implementation of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Germany. Zentralbl Chir 143(3):301\u2013306","journal-title":"Zentralbl Chir"},{"issue":"1","key":"989_CR15","first-page":"S52","volume":"138","author":"M Ried","year":"2013","unstructured":"Ried M, Neu R, Schalke B, Sziklavari Z, Hofmann HS (2013) Radical pleurectomy and hyperthermic intrathoracic chemotherapy for treatment of thymoma with pleural spread. Zentralbl Chir 138(1):S52\u2013S57","journal-title":"Zentralbl Chir"},{"issue":"3","key":"989_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/ejcts\/ezu217","volume":"47","author":"M Ried","year":"2015","unstructured":"Ried M, Lehle K, Neu R et\u00a0al (2015) Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure. Eur J Cardiothorac Surg 47(3):563\u2013566","journal-title":"Eur J Cardiothorac Surg"},{"key":"989_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00398-018-0260-8","volume":"33","author":"T Markowiak","year":"2019","unstructured":"Markowiak T, Hofmann HS, Ried M (2019) Z\u00a0Herz- Thorax- Gef\u00e4\u00dfchir 33:15. \n                    https:\/\/doi.org\/10.1007\/s00398-018-0260-8","journal-title":"Z Herz- Thorax- Gef\u00e4\u00dfchir"},{"issue":"9","key":"989_CR18","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jtho.2018.04.032","volume":"13","author":"BM Burt","year":"2018","unstructured":"Burt BM, Richards WG et\u00a0al (2018) A phase I trial of surgical resection and Intraoperative hyperthermic cisplatin and gemcitabine for pleural mesothelioma. J\u00a0Thorac Oncol 13(9):1400\u20131409","journal-title":"J Thorac Oncol"},{"key":"989_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jso.23321","volume":"107","author":"M Ried","year":"2013","unstructured":"Ried M, Potzger T, Braune N et\u00a0al (2013) Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies. J\u00a0Surg Oncol 107:735\u2013740","journal-title":"J Surg Oncol"},{"issue":"10","key":"989_CR20","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1245\/s10434-007-9508-3","volume":"14","author":"E De Bree","year":"2007","unstructured":"De Bree E, van Ruth S, Schotborgh CE, Baas P, Zoetmulder FA (2007) Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin. Ann Surg Oncol 14(10):3019\u20133026","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"989_CR21","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jtcvs.2017.10.070","volume":"155","author":"MC Ambrogi","year":"2018","unstructured":"Ambrogi MC, Bertoglio P, Aprile V et al (2018) Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience. J\u00a0Thorac Cardiovasc Surg 155(4):1857\u20131866.e2","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"989_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jtcvs.2012.10.042","volume":"145","author":"RB Cameron","year":"2012","unstructured":"Cameron RB, Hou D (2012) Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation. J\u00a0Thorac Cardiovasc Surg 145(2):496\u2013504","journal-title":"J Thorac Cardiovasc Surg"},{"key":"989_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3892\/ijo.2012.1715","volume":"42","author":"IL Cregan","year":"2013","unstructured":"Cregan IL, Dharmarajan AM, Fox SA (2013) Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: role of inhibitor of apoptosis proteins (IAPs) and caspases. Int J Oncol 42:444\u2013452","journal-title":"Int J Oncol"},{"issue":"7","key":"989_CR24","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.ejso.2017.02.010","volume":"43","author":"P Bertoglio","year":"2017","unstructured":"Bertoglio P, Ambrogi MC, Chella A et al (2017) Is less also better? A single-institution experience on treatment of early stage Malignant Pleural Mesothelioma. Eur J Surg Oncol 43(7):1365\u20131371","journal-title":"Eur J Surg Oncol"},{"key":"989_CR25","first-page":"885","volume-title":"Adult chest surgery","author":"DJ Sugarbaker","year":"2009","unstructured":"Sugarbaker DJ, Bueno R, Krasna MJ, Mentzer SJ, Zellos L (2009) Adult chest surgery. McGraw-Hill, New York, S 885\u2013890"},{"key":"989_CR26","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Malignant Pleural Mesothelioma. Version 2.2019\u2014April 1, 2019."},{"issue":"1","key":"989_CR27","doi-asserted-by":"publisher","first-page":"e000266","DOI":"10.1136\/bmjresp-2017-000266","volume":"5","author":"I Woolhouse","year":"2018","unstructured":"Woolhouse I, Bishop L, Darlison L et\u00a0al (2018) BTS guideline for the investigation and management of malignant pleural mesothelioma. BMJ Open Respir Res 5(1):e266. \n                    https:\/\/doi.org\/10.1136\/bmjresp-2017-000266","journal-title":"BMJ Open Respir. Res."},{"issue":"6","key":"989_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/ejcts\/ezv426","volume":"49","author":"M Ried","year":"2016","unstructured":"Ried M, Marx A, G\u00f6tz A, Hamer O, Schalke B, Hofmann HS (2016) State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma. Eur J Cardiothorac Surg 49(6):1545\u20131552","journal-title":"Eur J Cardiothorac Surg"},{"key":"989_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/OTT.S41347","volume":"6","author":"L Yu","year":"2013","unstructured":"Yu L, Jing Y, Ma S, Li F, Zhang YF (2013) Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination. Onco Targets Ther 6:517\u2013521","journal-title":"Onco Targets Ther"},{"issue":"1","key":"989_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ejcts\/ezv039","volume":"49","author":"MC Ambrogi","year":"2016","unstructured":"Ambrogi MC, Korasidis S, Lucchi M et\u00a0al (2016) Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy. Eur J Cardiothorac Surg 49(1):321\u2013326","journal-title":"Eur J Cardiothorac Surg"},{"issue":"18","key":"989_CR31","first-page":"313","volume":"110","author":"M Ried","year":"2013","unstructured":"Ried M, Hofmann HS (2013) The treatment of pleural carcinosis with malignant pleural effusion. Dtsch Arztebl Int 110(18):313\u2013318","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"989_CR32","doi-asserted-by":"publisher","first-page":"e5532","DOI":"10.1097\/MD.0000000000005532","volume":"96","author":"H Zhou","year":"2017","unstructured":"Zhou H, Wu W, Tang X, Zhou J, Shen Y (2017) Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis. Medicine (Baltimore) 96(1):e5532","journal-title":"Medicine (Baltimore)"},{"key":"989_CR33","doi-asserted-by":"crossref","first-page":"100640","DOI":"10.18632\/oncotarget.22062","volume":"8","author":"ZY Zhao","year":"2017","unstructured":"Zhao ZY, Zhao SS, Ren M et al (2017) Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a\u00a0systematic review and meta-analysis. Oncotarget 8:100640\u2013100647","journal-title":"Oncotarget"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0989-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-019-0989-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0989-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T23:07:44Z","timestamp":1592435264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-019-0989-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s00104-019-0989-y","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"19 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>H.-S.\u00a0Hofmann<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Chefarzt Klinik f\u00fcr Thoraxchirurgie Krankenhaus Barmherzige Br\u00fcder Regensburg | Leiter der Abteilung Thoraxchirurgie Universit\u00e4tsklinikum Regensburg | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Chirurgie, Deutsche Gesellschaft f\u00fcr Thoraxchirurgie, Deutsche Gesellschaft f\u00fcr Thorax\u2011, Herz- und Gef\u00e4\u00dfchirurgie, Deutsche Gesellschaft f\u00fcr Pathologie | Vizepr\u00e4sident Deutsche Gesellschaft f\u00fcr Thoraxchirurgie. <b>M.\u00a0Ried<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrender Oberarzt, Abteilung f\u00fcr Thoraxchirurgie, Universit\u00e4tsklinikum Regensburg | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Thoraxchirurgie, Deutsche Gesellschaft f\u00fcr Chirurgie und Vereinigung Bayerischer Chirurgen e.\u202fV.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}